Research study Program year 2025 Source: CMS Open Payments

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Gr

Research payments

$1,161,323

446 payments

Through program year 2025, $1,161,323 in research payments was reported against A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Gr, across 446 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$413,121	236
2024	Research	$679,838	192
2023	Research	$68,364	18

Breakdown

Who paid Research payments · program years 2023–2025

GlaxoSmithKline, LLC. $1,161,323 446 payments

Who received the money Research payments · program years 2023–2025

The Regents of The University of California Organisation paid for research $77,327 37 payments
Temple University Organisation paid for research $74,431 31 payments
Trustees Of The University Organisation paid for research $71,636 10 payments
Honorhealth Organisation paid for research $65,615 26 payments
The Johns Hopkins University Organisation paid for research $57,486 34 payments
The Regents Of The University Of Michigan Organisation paid for research $48,342 11 payments
Northwestern University Organisation paid for research $46,281 14 payments
The Regents University Of California Los Angeles Organisation paid for research $45,928 10 payments
The University of Arizona Organisation paid for research $45,713 38 payments
Regents University Of California Los Angeles Organisation paid for research $43,067 13 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.